Back to Search

A Phase 1/2 First-in-human Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Malignant Tumors


  • Protocol Number: 201905195
  • Principal Investigator: Morgensztern, Daniel
  • Cancer Types: Early Phase

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

Protocol Interventions